Navigation Links
Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
Date:6/3/2010

RESEARCH TRIANGLE PARK, N.C., June 3 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced the promotion of John R. Perkins to the position of executive vice president, global commercial operations.

In this leadership position, Perkins will be responsible for the global commercial business, including worldwide portfolio management, sales and marketing.

"John has demonstrated strong leadership and a proven track record of success," said Lawrence D. Stern, chairman and CEO of Talecris. "I am confident that his experience and diverse skill set will enable the seamless development and execution of our global strategies to drive global growth."

Perkins joined Talecris Biotherapeutics in 2006 and most recently served as the senior vice president and general manager, portfolio management and U.S. business.  He also serves on the board of directors for Centric Health Resources.

Prior to joining Talecris, Perkins was an operations executive at Cerberus Capital. He previously held a variety of positions at General Electric in corporate business development (M&A), marketing and product management, sales, operations and corporate audit.

Perkins received his Bachelor of Arts degree from DePauw University and his Master of Business Administration degree from Northwestern University's Kellogg School of Management.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation. Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis.


'/>"/>
SOURCE Talecris Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
2. Talecris Added to NASDAQ Biotechnology Index
3. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
4. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
5. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
6. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
7. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
9. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
10. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
11. Thomson Reuters Names the Worlds Hottest Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed ... both viscous and elastic characteristics when deformed, which is identical to how the ... gently absorb compressive forces and return to its natural state along a hysteresis ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
Breaking Biology Technology:
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
Breaking Biology News(10 mins):